With $850 million in dry powder to deploy from its second US dollar-denominated fund, China’s Genesis Capital is targeting Series C and D rounds for start-ups on the cusp of greatness
Genesis Capital’s sweet spot is defined by timing, as well as by industry and size: the Chinese growth-stage investor wants to back technology-enabled companies after their products are proven but before...
Abu Dhabi sovereign wealth fund Mubadala has agreed to invest INR90.9 billion ($1.2 billion) in Jio Platforms, the holding company for various internet and telecom assets owned by Indian oil-to-retail conglomerate Reliance Industries.
Bessemer Venture Partners has led an INR1.5 billion ($20 million) Series B round for teleconsultation health platform DocsApp.
Everest Medicines, a China-based biopharmaceutical company, has raised $310 million in Series C funding across two tranches.
Bespin Global, a Seoul and Beijing-based cloud management services provider, has raised RMB530 million ($74.6 million) in a Series C round from SK Telecom and existing investor DY Holdings.